Updated: January 23, 2026
Symdeko Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
- Common Side Effects of Symdeko
- Serious Side Effects: Call Your Doctor Right Away
- 1. Liver Problems (Elevated Transaminases)
- 2. Cataracts / Lens Opacities (Especially in Children)
- 3. Increased Brain Pressure (Intracranial Hypertension)
- 4. Serious Allergic Reactions
- 5. Mental Health Changes
- How Symdeko's Side Effects Compare to Other CFTR Modulators
- Tips for Managing Common Symdeko Side Effects
Learn about Symdeko's common and serious side effects, which symptoms require immediate medical attention, and how Symdeko's safety profile compares to other CFTR modulators.
Like all prescription medications, Symdeko (tezacaftor/ivacaftor) can cause side effects. Most patients tolerate Symdeko well — and its overall safety profile is considered favorable, especially compared to earlier CFTR modulators like Orkambi (lumacaftor/ivacaftor), which was more likely to cause respiratory side effects. Knowing what to expect and which symptoms require urgent medical attention can help you stay safe and on treatment.
Common Side Effects of Symdeko
In clinical trials involving more than 600 patients, the most commonly reported side effects of Symdeko (occurring in 3% or more of patients and more frequently than placebo) were:
Headache — the most commonly reported side effect; usually mild to moderate
Nausea — often manageable; taking Symdeko with fat-containing food may help reduce nausea
Sinus congestion (nasopharyngitis) — stuffy nose, sinus pressure, and related symptoms
Dizziness — can affect alertness; avoid driving or hazardous activities until you know how Symdeko affects you
These side effects are generally mild and often improve as your body adjusts to the medication. If any of these are bothersome or don't go away, contact your healthcare provider.
Serious Side Effects: Call Your Doctor Right Away
Symdeko can cause serious side effects in some patients. These require prompt medical attention:
1. Liver Problems (Elevated Transaminases)
Elevated liver enzymes (ALT and AST) have been reported in patients taking Symdeko. Your doctor will monitor your liver function with blood tests before you start Symdeko, every 3 months during the first year, and annually thereafter. Call your doctor right away if you experience:
Pain or discomfort in the upper right abdomen
Yellowing of the skin or whites of the eyes (jaundice)
Loss of appetite, dark urine, or unusual fatigue
2. Cataracts / Lens Opacities (Especially in Children)
Non-congenital lens opacities (cataracts) have been reported in pediatric and adolescent patients treated with Symdeko and with ivacaftor alone. The relationship between Symdeko and cataracts is not fully understood, but as a precaution, children and adolescents should have eye examinations before starting Symdeko and periodically during treatment. Contact your doctor if you or your child notice:
Blurred or cloudy vision
Increased sensitivity to light or glare
Difficulty seeing at night
3. Increased Brain Pressure (Intracranial Hypertension)
Intracranial hypertension (IH) — increased pressure around the brain — has been reported in post-marketing use of drugs containing the same ingredients as Symdeko. Symptoms of IH include severe headache, blurred vision, double vision, and potential vision loss. If you experience these symptoms, stop Symdeko and seek immediate medical evaluation.
4. Serious Allergic Reactions
Serious allergic reactions, including anaphylaxis, have been reported with Symdeko. Go to the emergency room or call 911 immediately if you experience:
Hives, rash, or itching
Difficulty breathing or swallowing
Swelling of the face, lips, tongue, or throat
5. Mental Health Changes
Serious mental health problems — including anxiety, depression, suicidal thoughts and behaviors, and sleep disturbances — have been reported in people taking Symdeko. If you or a family member notice new or worsening mental health symptoms while on Symdeko, contact your doctor right away. In a mental health emergency, call 988 (Suicide and Crisis Lifeline).
How Symdeko's Side Effects Compare to Other CFTR Modulators
Symdeko has a generally more favorable tolerability profile than Orkambi (lumacaftor/ivacaftor). Orkambi is associated with a higher risk of respiratory side effects — including chest tightness and shortness of breath — than Symdeko. Symdeko was developed in part to improve on Orkambi's tolerability, and clinical trials confirmed this advantage.
Compared to Trikafta (elexacaftor/tezacaftor/ivacaftor), both drugs share similar tolerability profiles since they contain overlapping active ingredients. Some patients who experience specific side effects on Trikafta may tolerate Symdeko better — this is a clinical discussion to have with your CF specialist.
Tips for Managing Common Symdeko Side Effects
Headache: Over-the-counter pain relievers (check with your doctor) may help. Staying hydrated is also important.
Nausea: Always take Symdeko with a fat-containing food (like peanut butter, eggs, or avocado) to improve absorption and reduce nausea.
Dizziness: Avoid driving or operating machinery until you know how Symdeko affects you. Report persistent dizziness to your doctor.
Sinus symptoms: Saline nasal rinses and OTC decongestants may help — ask your CF team before using any new OTC products.
For more information, see our full guide: Symdeko Drug Interactions: What to Avoid and What to Tell Your Doctor.
Need help finding your Symdeko prescription? medfinder calls pharmacies on your behalf to find out which ones can fill it.
Frequently Asked Questions
The most common Symdeko side effects reported in clinical trials are headache, nausea, sinus congestion (nasopharyngitis), and dizziness. These typically occur in at least 3% of patients and more often than placebo. Most are mild to moderate and often improve over time.
Elevated liver enzymes (ALT/AST) have been reported with Symdeko. While this doesn't always indicate liver damage, your doctor will monitor liver function with blood tests before starting Symdeko, every 3 months in the first year, and annually after that. Call your doctor immediately if you develop jaundice (yellowing skin/eyes), upper abdominal pain, or dark urine.
Non-congenital lens opacities (cataracts) have been reported in children and adolescents taking Symdeko and ivacaftor. A causal relationship has not been definitively established, but as a precaution, eye exams are recommended before and during treatment for pediatric patients. Report any vision changes to your doctor promptly.
Yes — serious mental health problems including anxiety, depression, and suicidal thoughts have been reported with Symdeko. These are listed as serious side effects in the prescribing information. If you or a family member experiences new or worsening mental health symptoms while taking Symdeko, contact your doctor right away or call 988 (Suicide and Crisis Lifeline).
No — respiratory side effects like chest tightness and shortness of breath are far less common with Symdeko than with Orkambi (lumacaftor/ivacaftor). Symdeko was developed in part to improve on Orkambi's tolerability, and clinical data confirms a significantly lower rate of respiratory adverse events with Symdeko.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Symdeko also looked for:
More about Symdeko
30,831 have already found their meds with Medfinder.
Start your search today.





